Novarex introduces a new product to the US marketplace called Rexflavone. Rexflavone is a extract from the Sophora japonica Linne fruits.
Already popular in Korea, Novarex proudly introduces Rexflavone to the US market in 2017.
Novarex has successfully completed a randomized, double blind, placebo controlled clinical trial on women using Rexflavone for menopause. Testing certification analysis has been completed on Rexflavone in the US by a 3rd independent company and Novarex has received NDIN by the FDA. Novarex has also received FDA letter acknowledging satisfied legal requirements for marketing Rexflavone for menopause and osteoporosis support in the US.
Novarex Co. Ltd. is a leading OEM / ODM company for health supplements in South Korea. Established in 1995 under the name Rexgene Biotech. Co. Ltd. Novarex holds many domestic and international patents.
Currently, Novarex makes over 1,200 functional ingredients and food supplements.
Novarex is well recognized in the international market place with top brand customers such as GNC, Blackmores and Asian companies.
Please reach out if you have any questions or would like samples of this amazing fruit extract Rexflavone.